No Cover Image

Journal article 62 views

TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunities.

Zenobia C. D’Costa, Catherine Higgins, Chee Wee Ong, Gareth W. Irwin, David Boyle, Darragh G. McArt, Karen McCloskey, Niamh E. Buckley, Nyree T. Crawford, Lalitha Thiagarajan, James Murray Orcid Logo, Richard D. Kennedy, Karl A. Mulligan, D. Paul Harkin, David J.J. Waugh, Chris J. Scott, Manuel Salto-Tellez, Richard Williams, Paul B. Mullan

Oncotarget, Volume: 5, Issue: 6, Pages: 1609 - 1620

Swansea University Author: James Murray Orcid Logo

Full text not available from this repository: check for access using links below.

Published in: Oncotarget
ISSN: 1949-2553
Published: Impact Journals, LLC 2014
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa56402
Tags: Add Tag
No Tags, Be the first to tag this record!
Keywords: TBX2, CST6, LGMN, breast cancer
College: Swansea University Medical School
Issue: 6
Start Page: 1609
End Page: 1620